Generation of mesenchymal stromal cells in the presence of platelet lysate: a phenotypic and functional comparison of umbilical cord blood- and bone marrow-derived progenitors.
about
Pathogen-free, plasma-poor platelet lysate and expansion of human mesenchymal stem cellsPlatelet lysate as a substitute for animal serum for the ex-vivo expansion of mesenchymal stem/stromal cells: present and futureMesenchymal stem/stromal cells: a new ''cells as drugs'' paradigm. Efficacy and critical aspects in cell therapyImmunoregulation by mesenchymal stem cells: biological aspects and clinical applicationsIn vitro biosafety profile evaluation of multipotent mesenchymal stem cells derived from the bone marrow of sarcoma patients.The production method affects the efficacy of platelet derivatives to expand mesenchymal stromal cells in vitro.Human mesenchymal stromal cells from adult and neonatal sources: a comparative in vitro analysis of their immunosuppressive properties against T cells.Clinical observation of umbilical cord mesenchymal stem cell treatment of severe idiopathic pulmonary fibrosis: A case report.The Good the Bad and the Ugly of Glycosaminoglycans in Tissue Engineering ApplicationsRelevance of the mevalonate biosynthetic pathway in the regulation of bone marrow mesenchymal stromal cell-mediated effects on T-cell proliferation and B-cell survivalHuman mesenchymal stem cells from chorionic villi and amniotic fluid are not susceptible to transformation after extensive in vitro expansion.Mesenchymal stromal cells from human perinatal tissues: From biology to cell therapy.Human adipose-derived mesenchymal stem cells as a new model of spinal and bulbar muscular atrophy.Mesenchymal stromal cells for cutaneous wound healing in a rabbit model: pre-clinical study applicable in the pediatric surgical setting.Stem cell therapy for neonatal diseases associated with preterm birth.Potency testing of mesenchymal stromal cell growth expanded in human platelet lysate from different human tissuesThe plasma levels of soluble HLA-G molecules correlate directly with CD34+ cell concentration and HLA-G 14bp insertion/insertion polymorphism in cord blood donors.Generation of mesenchymal stromal cells from cord blood: evaluation of in vitro quality parameters prior to clinical use.HLA-G in organ transplantation: towards clinical applications.Unravelling the pluripotency paradox in fetal and placental mesenchymal stem cells: Oct-4 expression and the case of The Emperor's New Clothes.Controlled release strategies for bone, cartilage, and osteochondral engineering--Part II: challenges on the evolution from single to multiple bioactive factor delivery.Serum-free media for the production of human mesenchymal stromal cells: a review.Platelet lysate as replacement for fetal bovine serum in mesenchymal stromal cell cultures.Adult adherent stromal cells in the management of graft-versus-host disease.Partnership between platelet-rich plasma and mesenchymal stem cells: in vitro experience.Unraveling mechanisms of mesenchymal stromal cell-mediated immunomodulation through patient monitoring and product characterization.Culture of human cell lines by a pathogen-inactivated human platelet lysate.Biological activity of a standardized freeze-dried platelet derivative to be used as cell culture medium supplement.Resistance to neoplastic transformation of ex-vivo expanded human mesenchymal stromal cells after exposure to supramaximal physical and chemical stress.Isolation of mesenchymal stromal/stem cells from small-volume umbilical cord blood units that do not qualify for the banking system.Human Platelet Lysate as a Xeno Free Alternative of Fetal Bovine Serum for the In Vitro Expansion of Human Mesenchymal Stromal Cells.Optimization of human mesenchymal stem cell manufacturing: the effects of animal/xeno-free media.Comparative analysis of human mesenchymal stem cells from bone marrow, adipose tissue, and umbilical cord blood as sources of cell therapy.Human mesenchymal stem cells from the umbilical cord matrix: successful isolation and ex vivo expansion using serum-/xeno-free culture media.Efficacy and safety of human umbilical cord derived mesenchymal stem cell therapy in children with severe aplastic anemia following allogeneic hematopoietic stem cell transplantation: a retrospective case series of 37 patients.Human platelet lysate supplementation of mesenchymal stromal cell delivery: issues of xenogenicity and species variability.Platelet Lysate: The Better Choice for Jaw Periosteal Cell Mineralization.Mesenchymal Stromal Cells in Hematopoietic Stem Cell Transplantation.Chorionic villi derived mesenchymal like stem cells and expression of embryonic stem cells markers during long-term culturing.Isolation and characterization of mesenchymal stem cells from human umbilical cord blood: reevaluation of critical factors for successful isolation and high ability to proliferate and differentiate to chondrocytes as compared to mesenchymal stem cel
P2860
Q21245484-0C464DD5-B936-4012-A57E-8F82D59DFA1FQ26740490-3250368F-9414-4244-919C-3E2E5DB6B2B3Q26825272-E3B6660B-816F-4B57-BF5D-47B1F9AECA0FQ27026892-6804DD24-35E7-498C-BA38-2764282EE6CCQ33616791-06FC96DE-5650-4766-89D1-8941EE811831Q33623503-BE79C16E-2E78-499C-AE9F-7A0984148482Q33637705-335668E1-5BD5-4BAD-8DBC-1551A1AB38DAQ33724205-A8445DA5-5251-4297-A0F8-B42063944C45Q33851544-8BC43151-EAC8-4F1A-A103-FD0B734B5599Q34451498-77EF2FB4-22EF-450C-A31A-D509A2A29043Q34625007-0F8CFD9E-C225-4888-A660-BE7775F0840BQ34992282-8EAC786C-D6E9-474E-9D9B-3E9613696766Q35416623-28A649DE-98C5-4968-A59C-9523832AAD0BQ35685469-E5C6A081-2143-4775-89E4-D772B4F2704AQ37144573-22D85449-1B8E-4313-8686-403E58391DB4Q37203386-3EE9C3C1-9DF2-465A-A949-03632F8861D7Q37602425-EBA0454A-18EB-453A-84F4-C5A7DAB7AAEAQ37602625-61C82B6C-AFDE-4153-828F-1882697DE8E1Q37811950-72C27E72-B3B5-43A1-9819-BF87D5B9C1CDQ37967561-04C19440-754F-410F-94F2-80F8EC090746Q38068244-5868AFC6-F956-45AD-B421-0AB4D233DC6BQ38151905-6AA81EB2-9172-4812-B233-40EFB29FA91FQ38165928-B49D36CC-A5A7-4FEC-BE76-E48C681EFB57Q38176442-09C4B1F3-499A-4957-9C25-64F7DA823155Q38220508-13FCA260-CF57-4B3F-87E0-B892C64B4D0FQ38682125-34D6C39F-A45C-4B61-AA4F-F2A53FBFFA21Q38878693-C97AD08B-6183-411C-BB07-B25910BF216BQ39120525-73181670-FAE1-4B02-813D-89AD975B96D7Q39266167-AE4BAB77-680C-406E-9587-31619AC7B735Q40785927-2D1BCE51-3951-4185-8EF8-A726608EF27DQ41788059-7A4832FD-8120-4721-8527-42893EC705A2Q41881764-50E79423-D510-4E16-BF00-4585C2DC23A3Q42663878-36AF6D65-AB19-4976-9034-7C6D86D6E8B3Q44297451-5BD98F85-ADB9-4793-BBD6-F4B8E3DBC4FEQ44605231-D58390E4-ADFF-4982-B75E-0C24F87A8D33Q46528085-30ACF69A-AB49-4895-833B-CD4CA9AE686DQ48119867-F55D1FCE-3CDF-4085-82E5-F1275801C780Q53092701-969A0669-177B-4098-98DB-AD6273736652Q53109461-67DA3D69-371C-42B9-95A2-EF4FBDA420F0Q54388224-8A17A757-EA41-40E7-8DAB-C7EF80C2408F
P2860
Generation of mesenchymal stromal cells in the presence of platelet lysate: a phenotypic and functional comparison of umbilical cord blood- and bone marrow-derived progenitors.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 22 September 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Generation of mesenchymal stro ...... ne marrow-derived progenitors.
@en
Generation of mesenchymal stro ...... ne marrow-derived progenitors.
@nl
type
label
Generation of mesenchymal stro ...... ne marrow-derived progenitors.
@en
Generation of mesenchymal stro ...... ne marrow-derived progenitors.
@nl
prefLabel
Generation of mesenchymal stro ...... ne marrow-derived progenitors.
@en
Generation of mesenchymal stro ...... ne marrow-derived progenitors.
@nl
P2093
P2860
P50
P1433
P1476
Generation of mesenchymal stro ...... one marrow-derived progenitors
@en
P2093
Angela Maria Cometa
Antonia Moretta
Cesare Perotti
Franco Locatelli
Livia Visai
Lynne M Ball
Maria Antonietta Avanzini
Maria Ester Bernardo
Raffaella Villa
Rita Maccario
P2860
P304
P356
10.3324/HAEMATOL.2009.006171
P577
2009-09-22T00:00:00Z